Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.62
24.03.21
€145.00
24.03.22
-1.26%
09.04.21

Known brand
Future proof or reliable business model
Medium risks for its business
phonebroker 
24.03.21 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
19.06.20 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
tinelchen 
24.02.21 0%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€138.90
05.02.21
-
31.12.21
0.09%
29.03.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilbert 
05.02.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
18.12.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
-
04.11.21
-22.67%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
03.10.20 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€64.63
25.02.21
€70.00
3.84%
08.03.21

Could be worthwhile Investment >10% per year
Traumtanz 
25.02.21 50%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€72.06
20.12.20
-
20.12.21
-7.02%
21.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
20.12.20 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€219.23
21.01.21
€215.00
2.46%
15.02.21

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Traumtanz 
21.01.21 50%
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
CrazyEights 
20.11.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€134.68
20.01.21
€144.00
0.89%
02.02.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
Gilbert 
20.01.21 60%
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
ValueFreak 
30.07.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.17
18.12.20
€27.00
18.06.21
14.83%
19.01.21

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
18.12.20 50%
buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
NightTrain 
03.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€395.05
12.12.20
-
12.12.21
4.78%
09.01.21

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
12.12.20 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.80
17.03.20
€16.00
04.11.21
0.00%
06.01.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
gerihouse 
17.03.20 50%
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€89.88
30.10.20
-
04.11.21
7.35%
03.01.21

Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
CandyButcher 
30.10.20 50%
buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€371.00
29.10.20
-
04.11.21
8.65%
30.12.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
GraveDigger 
29.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.01
18.12.20
€45.00
-1.78%
23.12.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
18.12.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.91
17.12.20
€29.00
-1.81%
21.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
17.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%
sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€392.75
11.12.20
€250.00
0.97%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
11.12.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
22.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

FinanceClub_UoM 
16.11.20 50%